Performance of Modified Pneumonia Severity Indexes in Community-Acquired Pneumonia
Aim: In patients with community-acquired pneumonia, we observed that the impact of the age variable commonly used in Pneumonia Severity scores to predict mortality risk is disproportionate within the pneumonia severity index (PSI). In this context, our study aimed to evaluate and compare the effecti...
| Published in: | Eurasian Journal of Emergency Medicine |
|---|---|
| Main Authors: | Yasemin Yılmaz, Aynur Yurtseven |
| Format: | Article |
| Language: | English |
| Published: |
Emergency Medicine Physicians’ Association of Turkey
2025-09-01
|
| Subjects: | |
| Online Access: | https://eajem.com/articles/performance-of-modified-pneumonia-severity-indexes-in-community-acquired-pneumonia/doi/eajem.galenos.2025.97455 |
Similar Items
Assement of Severity of Community Acquired Pneumonia By CURB-65
by: Ahmed Talal Abdullah, et al.
Published: (2019-06-01)
by: Ahmed Talal Abdullah, et al.
Published: (2019-06-01)
Assement of Severity of Community Acquired Pneumonia By CURB-65
by: Ahmed Talal Abdullah, et al.
Published: (2019-06-01)
by: Ahmed Talal Abdullah, et al.
Published: (2019-06-01)
Hyponatremia in Community Acquired Pneumonia in a Tertiary Care Hospital - An Observational Cross-Sectional Study
by: Mumina Ramzan, et al.
Published: (2021-10-01)
by: Mumina Ramzan, et al.
Published: (2021-10-01)
The Performance of CURB-65 and PSI for Predicting In-Hospital Mortality of Community-Acquired Pneumonia in Patients with Type 2 Diabetes Compared with the Non-Diabetic Population
by: Ma CM, et al.
Published: (2021-03-01)
by: Ma CM, et al.
Published: (2021-03-01)
Comparison between CURB-65, PSI, and SIPF scores as predictors of ICU admission and mortality in community-acquired pneumonia
by: Safwat A.M. Eldaboosy, et al.
Published: (2015-08-01)
by: Safwat A.M. Eldaboosy, et al.
Published: (2015-08-01)
Acute phase reactants in non-COVID-19 community-acquired pneumonia
by: Yosri Akl, et al.
Published: (2023-10-01)
by: Yosri Akl, et al.
Published: (2023-10-01)
EMR Combined with CRB-65 Superior to CURB-65 in Predicting Mortality in Patients with Community-Acquired Pneumonia
by: Sun Y, et al.
Published: (2024-02-01)
by: Sun Y, et al.
Published: (2024-02-01)
Comparative analysis of the prognostic significance of the CURB-65 and CRB-65 scores and their modifications in hospital mortality assessment in patients with community-acquired pneumonia
by: D. A. Vinokurova, et al.
Published: (2024-04-01)
by: D. A. Vinokurova, et al.
Published: (2024-04-01)
EMR Combined with CRB-65 Superior to CURB-65 in Predicting Mortality in Patients with Community-Acquired Pneumonia [Letter]
by: Rusdi AJ, et al.
Published: (2024-03-01)
by: Rusdi AJ, et al.
Published: (2024-03-01)
Prognostic value of CURB-65 and pneumonia severity index (PSI) in COVID-19 pneumonia: A retrospective cohort study
by: Pankaj Kumar Jain, et al.
Published: (2024-11-01)
by: Pankaj Kumar Jain, et al.
Published: (2024-11-01)
EMR Combined with CRB-65 Superior to CURB-65 in Predicting Mortality in Patients with Community-Acquired Pneumonia [Response to Letter]
by: Sun Y, et al.
Published: (2024-04-01)
by: Sun Y, et al.
Published: (2024-04-01)
Correlational study of Vitamin-D deficiency levels and its severity of community-acquired pneumonia in patients admitted into a tertiary care hospital
by: Sai Varun M, et al.
Published: (2024-04-01)
by: Sai Varun M, et al.
Published: (2024-04-01)
NT-proBNP correlates with the illness scores pneumonia severity index and CURB-65 in patients with pneumonia
by: Dario Martolini, et al.
Published: (2017-03-01)
by: Dario Martolini, et al.
Published: (2017-03-01)
Association of serum procalcitonin and C-reactive protein levels with CURB-65 criteria among patients with community-acquired pneumonia
by: Keramat F, et al.
Published: (2018-06-01)
by: Keramat F, et al.
Published: (2018-06-01)
Role of biomarkers in community-acquired pneumonia management
by: Bahaeddin Onur, et al.
Published: (2024-07-01)
by: Bahaeddin Onur, et al.
Published: (2024-07-01)
Features of laboratory indicators of severe community-acquired pneumonia
by: Pertzeva T.A., et al.
Published: (2017-06-01)
by: Pertzeva T.A., et al.
Published: (2017-06-01)
Beyond the Symptoms: Exploring the Clinical, Bacteriological, and Radiological Profiles and Outcomes of Community-Acquired, Hospital-Acquired, and Ventilator-Associated Pneumonia in a Tertiary Care Setting
by: Shashi Bhusan Rao Kelli, et al.
Published: (2024-01-01)
by: Shashi Bhusan Rao Kelli, et al.
Published: (2024-01-01)
Features of laboratory indicators of severe community-acquired pneumonia.
by: T. A. Pertzeva, et al.
Published: (2017-06-01)
by: T. A. Pertzeva, et al.
Published: (2017-06-01)
Тhe features of severe community acquired pneumonia
by: Avramenko I.V.
Published: (2015-06-01)
by: Avramenko I.V.
Published: (2015-06-01)
Тhe features of severe community acquired pneumonia.
by: I. V. Avramenko
Published: (2015-06-01)
by: I. V. Avramenko
Published: (2015-06-01)
Adherence to National Antimicrobial Guidelines in Hospitalized Geriatric Patients with Community-Acquired Pneumonia: A Prospective Observational study in a Malaysian Hospital
by: Sadia Shakeel, et al.
Published: (2021-12-01)
by: Sadia Shakeel, et al.
Published: (2021-12-01)
3 Utility of Free Web Based Software for Identifying Potentially Teratogenic Medicines In Pregnancy
by: Anupma, et al.
Published: (2022-01-01)
by: Anupma, et al.
Published: (2022-01-01)
Usefulness of CURB-65 and Pneumonia Severity Index for Influenza A H1N1v pneumonia
by: Angel Estella
Published: (2015-12-01)
by: Angel Estella
Published: (2015-12-01)
Performance of CURB-65 in predicting mortality of patients with community-acquired pneumonia in Saudi Arabia
by: Jaffar A. Al-Tawfiq, et al.
Published: (2017-10-01)
by: Jaffar A. Al-Tawfiq, et al.
Published: (2017-10-01)
Validation of C-Reactive Protein and CURB-65 in The First Hospital Admission Community Acquired Pneumonia Patient as A Predictor 30 Days Mortality
by: Borries Foresto Buharman, et al.
Published: (2018-03-01)
by: Borries Foresto Buharman, et al.
Published: (2018-03-01)
Prognostic Value of Procalcitonin in Pneumonia among Patients Admitted to Intensive Care Unit.
by: Deok Hee Kim, et al.
Published: (2019-06-01)
by: Deok Hee Kim, et al.
Published: (2019-06-01)
Revolutionizing Pneumonia Assessment: Modern Diagnostics and Traditional Scales
by: Marcelina Sikora, et al.
Published: (2024-01-01)
by: Marcelina Sikora, et al.
Published: (2024-01-01)
The forecasting of development of lung fibrosis after suffering a severe community-acquired pneumonia.
by: I. V. Avramenko
Published: (2018-05-01)
by: I. V. Avramenko
Published: (2018-05-01)
Problems of assessing the severity of the state of elderly patients with community-acquired pneumonia caused by Klebsiella pneumoniae
by: V. I. Sakharov, et al.
Published: (2020-12-01)
by: V. I. Sakharov, et al.
Published: (2020-12-01)
Cytokine profile in community-acquired pneumonia in children
by: N. V. Iziurova, et al.
Published: (2022-11-01)
by: N. V. Iziurova, et al.
Published: (2022-11-01)
Can We Improve Confusion, Uremia, Respiratory Rate, Blood Pressure, Age >65 with Lactate and Procalcitonin to Predict Mortality in Pneumonia?
by: Ahmet Burak Urfalioglu, et al.
Published: (2023-07-01)
by: Ahmet Burak Urfalioglu, et al.
Published: (2023-07-01)
The effect of taking antibacterial therapy on the outpatient stage and outcomes of community-acquired pneumonia in Tomsk hospitals
by: Daria A. Vinokurova, et al.
Published: (2024-01-01)
by: Daria A. Vinokurova, et al.
Published: (2024-01-01)
Hyponatremia in Patients with Community Acquired Pneumonia
by: Lochan Karki, et al.
Published: (2016-06-01)
by: Lochan Karki, et al.
Published: (2016-06-01)
Assessment of the prognosis of the outcome of severe community-acquired pneumonia caused by <i>Klebsiella pneumoniae</i>
by: V. I. Sakharov, et al.
Published: (2023-12-01)
by: V. I. Sakharov, et al.
Published: (2023-12-01)
Characteristics and Management of Community-Acquired Pneumonia in the Era of Global Aging
by: Catia Cillóniz, et al.
Published: (2018-04-01)
by: Catia Cillóniz, et al.
Published: (2018-04-01)
Severe community-acquired pneumonia: principles of diagnostics and intensive therapy
by: V.I. Chernii
Published: (2023-09-01)
by: V.I. Chernii
Published: (2023-09-01)
Impact of infectious etiology on the outcome of Taiwanese patients hospitalized with community acquired pneumonia
by: Yuan-Ti Lee, et al.
Published: (2013-02-01)
by: Yuan-Ti Lee, et al.
Published: (2013-02-01)
Nonlinear main components of the cytokine profile in children with community-acquired pneumonia
by: N. V. Iziurova, et al.
Published: (2024-01-01)
by: N. V. Iziurova, et al.
Published: (2024-01-01)
Hospital Admission Patterns in Adult Patients with Community-Acquired Pneumonia Who Received Ceftriaxone and a Macrolide by Disease Severity across United States Hospitals
by: Thomas P. Lodise, et al.
Published: (2020-09-01)
by: Thomas P. Lodise, et al.
Published: (2020-09-01)
Differences in pulmonary microbiota of severe community-acquired pneumonia with different pathogenic microorganisms in children
by: Yingying Luo, et al.
Published: (2025-06-01)
by: Yingying Luo, et al.
Published: (2025-06-01)
Similar Items
-
Assement of Severity of Community Acquired Pneumonia By CURB-65
by: Ahmed Talal Abdullah, et al.
Published: (2019-06-01) -
Assement of Severity of Community Acquired Pneumonia By CURB-65
by: Ahmed Talal Abdullah, et al.
Published: (2019-06-01) -
Hyponatremia in Community Acquired Pneumonia in a Tertiary Care Hospital - An Observational Cross-Sectional Study
by: Mumina Ramzan, et al.
Published: (2021-10-01) -
The Performance of CURB-65 and PSI for Predicting In-Hospital Mortality of Community-Acquired Pneumonia in Patients with Type 2 Diabetes Compared with the Non-Diabetic Population
by: Ma CM, et al.
Published: (2021-03-01) -
Comparison between CURB-65, PSI, and SIPF scores as predictors of ICU admission and mortality in community-acquired pneumonia
by: Safwat A.M. Eldaboosy, et al.
Published: (2015-08-01)
